|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,586.00 INR | +1.72% |
|
-6.87% | +133.32% |
| Market Cap | 13.55B 142M 123M 115M 105M 199M 202M 1.35B 532M 6.75B 533M 522M 22.63B | P/E 2024 |
17.9x | P/E 2025 | 22.6x |
|---|---|---|---|---|---|
| Enterprise Value | 14.53B 152M 132M 123M 113M 214M 217M 1.45B 570M 7.23B 572M 559M 24.26B | EV / Sales 2024 |
1.68x | EV / Sales 2025 | 2.7x |
| Free-Float |
21.45% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +1.72% | ||
| 1 week | -6.87% | ||
| 1 month | -7.71% | ||
| 3 months | +63.52% | ||
| 6 months | +142.75% | ||
| Current year | +133.32% |
| 1 week | 2,521.8 | 2,837.55 | |
| 1 month | 2,512.25 | 2,849.35 | |
| Current year | 1,020 | 2,889 | |
| 1 year | 828.8 | 2,889 | |
| 3 years | 308.7 | 2,889 | |
| 5 years | 244.9 | 2,889 | |
| 10 years | 21.3 | 2,889 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ramesh Arora
CEO | Chief Executive Officer | 72 | 03/05/1983 |
Aditya Arora
DFI | Director of Finance/CFO | 32 | 21/10/2015 |
Mukesh Ojha
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Ramesh Arora
BRD | Director/Board Member | 72 | 03/05/1983 |
Ajay Kumar Arora
BRD | Director/Board Member | 58 | 31/07/1995 |
Anju Arora
BRD | Director/Board Member | 64 | 30/09/2010 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.72% | -6.87% | +125.87% | +626.51% | 281M | ||
| -0.53% | -3.95% | +55.23% | +152.74% | 1,024B | ||
| +0.21% | -2.68% | +55.61% | +53.02% | 618B | ||
| -2.51% | -3.25% | +32.76% | +67.76% | 443B | ||
| +0.06% | -0.42% | +37.53% | +30.67% | 349B | ||
| -0.14% | -0.24% | +34.41% | +39.01% | 297B | ||
| -0.69% | -0.30% | +11.55% | +12.93% | 264B | ||
| -7.37% | -4.40% | -2.54% | -43.87% | 209B | ||
| -0.64% | +2.43% | +30.52% | +64.49% | 208B | ||
| -0.82% | +0.70% | +15.96% | +71.01% | 162B | ||
| Average | -1.07% | -1.76% | +39.69% | +107.43% | 357.4B | |
| Weighted average by Cap. | -0.99% | -1.93% | +39.25% | +73.00% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 3.07B 32.18M 27.97M 26.04M 23.9M 45.14M 45.84M 307M 120M 1.53B 121M 118M 5.13B | 3.7B 38.78M 33.71M 31.38M 28.81M 54.4M 55.25M 370M 145M 1.84B 146M 142M 6.18B |
| Net income | 238M 2.49M 2.17M 2.02M 1.85M 3.5M 3.55M 23.78M 9.33M 118M 9.36M 9.16M 397M | 398M 4.17M 3.63M 3.38M 3.1M 5.86M 5.95M 39.81M 15.62M 198M 15.68M 15.33M 665M |
| Net Debt | 922M 9.66M 8.39M 7.81M 7.17M 13.55M 13.76M 92.09M 36.14M 459M 36.26M 35.47M 1.54B | 977M 10.23M 8.9M 8.28M 7.6M 14.36M 14.58M 97.6M 38.31M 486M 38.43M 37.59M 1.63B |
Employees
997
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/07/26 | ₹2,586.00 | +1.72% | 4,127 |
| 30/07/26 | ₹2,542.30 | -2.33% | 2,482 |
| 29/07/26 | ₹2,603.05 | +0.53% | 3,502 |
| 28/07/26 | ₹2,589.35 | -4.56% | 8,450 |
| 27/07/26 | ₹2,713.20 | -2.29% | 2,516 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- KPL Stock
Select your edition
All financial news and data tailored to specific country editions
















